Products - Headaches | Topic | NICE

Showing 5 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Atogepant for treating migraine [ID6615]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
9 July 2026
Transvenous embolisation for spontaneous intracranial hypotension caused by a cerebrospinal fluid–venous fistula
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Botulinum toxin type A for preventing episodic migraine [ID6450]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Secukinumab for treating giant cell arteritis in people 50 years and over [ID6563]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Headaches (update): Prophylactic treatment of migraine - Candesartan
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC